Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
CN Stock MarketDetailed Quotes
600538 Beihai Gofar Chuanshan Biological
- 5.31
- +0.09+1.72%
Market Closed Apr 30 15:00 CST
2.78BMarket Cap-35.64P/E (TTM)
5.32High5.17Low74.21KlotVolume5.24Open5.22Pre Close39.12MTurnover1.42%Turnover RatioLossP/E (Static)524.20MShares6.4052wk High3.58P/B2.78BFloat Cap2.9052wk Low5.74Limit Up524.20MShs Float19.58Historical High4.70Limit Down2.87%Amplitude1.85Historical Low--Dividend TTM5.27Avg Price27.39KlotAsk--Div YieldTTM100Lot Size46.51KlotBid
About Beihai Gofar Chuanshan Biological Company
The company was registered with the Beihai Administration for Industry and Commerce on January 22, 1993, and is headquartered in Beihai City, Guangxi Zhuang Autonomous Region. The company's shares were listed and traded on the Shanghai Stock Exchange on January 14, 2003. The main industries the company operates include pharmaceutical manufacturing and pharmaceutical distribution, judicial IVD (in vitro diagnosis), molecular medical imaging centers, etc. The company's main products include “Haibao” pearl eye drops, pearl powder, pearl layer powder, “Guofa” brand gastroenterology granules, honeysuckle mixture, fertilizer syrup, “Haima” brand medicinal liquor, sea snake medicinal alcohol, etc., pharmaceutical and medical device products; judicial DNA testing equipment and reagent consumables. Corporate honors: “Best Practice for Listed Companies 2022 Report Performance Briefing”, National Key New Products, National Key New Products, Beihai Guofa Biopesticides Award Certificate, etc.
Company Profile
Short Name-A国发股份
Symbol-A600538
Company NameBeihai Gofar Chuanshan Biological Co., Ltd.
Listing DateJan 14, 2003
Issue Price6.69
Shares Offered45.00M share(s)
FoundedJan 22, 1993
Listed ExchangeSH Stock Exchange
Legal Representativeye jiang
General Managerxiaowei zhang
Secretaryyong li
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativeliping li
Legal CounselBeijing Times Jiuhe Law Firm
Employees147
Phone0779-3200619
Office AddressNo. 3 Beibuwan Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
Zip Code536000
Registered AddressNo. 3 Beibuwan Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
Fax0779-3200618
Emailsecurities@gofar.com.cn
Websitehttp://www.gofar.com.cn
Business License450500000008877
BusinessLicense projects: pharmaceutical wholesale; pharmaceutical retail; pharmaceutical production; production of second-class medical devices; production of disinfectants (excluding hazardous chemicals); medical services; real estate development and operation. (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses). General projects: medical research and experimental development; research and development of marine bioactive substance extraction, purification, synthesis technology; investment activities with own funds; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; non-residential real estate leasing; advertising; sales of arts and crafts and ceremonial goods (other than ivory and its products); sales of class II medical devices; sales of disinfectants (excluding hazardous chemicals). (With the exception of projects subject to approval according to law, business activities are carried out independently in accordance with the law on the basis of a business license).
Company Executives
- Name
- Position
- Salary
- ye jiang
- Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee
- 33.80K
- peicheng wu
- Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee
- 104.00K
- zhibo yin
- Directors, VP, Chief Financial Officer, Strategy Committee Member
- 1.12M
- xiaowei zhang
- Directors, President, Strategy Committee Member
- --
- tao peng
- Directors, Strategy Committee Member
- 80.00K
- yong li
- Directors, Board Secretary, VP
- 1.05M
- xiaofang song
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 100.00K
- yanlin ceng
- Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member
- 100.00K
- zeyang xu
- Independent Directors, Chairman of the Remuneration and Assessment Committee, Audit Committee Member, Nomination Committee Members
- 100.00K
- liping li
- Securities Affairs Representative
- --
- qiujun lv
- Chairman of the Supervisory Board, Auditors
- 80.00K
- zhenhua huang
- Auditors
- 50.00K
- libin pan
- Senior Advisors
- 1.81M
- yan chen
- Employee Supervisors
- 227.70K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts